Comparison of the prognostic value of RR-interval variability after acute myocardial infarction in patients with versus those without diabetes mellitus

American Journal of Cardiology

Volumn 92, Issue 3, 2003, Pages 247-251

  Whang, William ^a   Bigger Jr , J Thomas ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIURETIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; ECG ABNORMALITY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPOTHESIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RR INTERVAL; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

EID: 0042848554     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00618-0     Document Type: Article

References (25)

1. Smith J.W., Marcus F.I., Serokman R. Prognosis of patients with diabetes mellitus after acute myocardial infarction. Am J Cardiol. 54:1984;718-721.
2. Stone P.H., Muller J.E., Hartwell T., York B.J., Rutherford J.D., Parker C.B., Turi Z.G., Strauss H.W., Willerson J.T., Robertson T. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis . J Am Coll Cardiol. 14:1989;49-57.
3. Capone R.J., Pawitan Y., el-Sherif N., Geraci T.S., Handshaw K., Morganroth J., Schlant R.C., Waldo A.L. Events in the Cardiac Arrhythmia Suppression Trial baseline predictors of mortality in placebo-treated patients . J Am Coll Cardiol. 18:1991;1434-1438.
4. Zuanetti G., Latini R., Maggioni A.P., Santoro L., Grazia Franzosi M. Influence of diabetes on mortality in acute myocardial infarction data from the GISSI-2 study . J Am Coll Cardiol. 22:1993;1788-1794.
5. Abbud Z.A., Shindler D.M., Wilson A.C., Kostis J.B. Effect of diabetes mellitus on short- and long-term mortality rates of patients with acute myocardial infarction a statewide study . Am Heart J. 130:1995;51-58.
6. Ewing D.J., Martyn C.N., Young R.J., Clarke B.F. The value of cardiovascular autonomic function tests 10 years experience in diabetes . Diabetes Care. 8:1985;491-498.
7. Ewing D.J., Campbell I.W., Clarke B.F. The natural history of diabetic autonomic neuropathy. Quart J Med. 49:1980;95-108.
8. Navarro X., Kennedy W.R., Loewenson R.B., Sutherland D.E.R. Influence of pancreas transplantation on cardiorespiratory reflexes, nerve conduction, and mortality in diabetes mellitus. Diabetes. 39:1990;802-806.
9. Sampson M.J., Wilson S., Karagiannis P., Edmonds M., Watkins P.J. Progression of diabetic autonomic neuropathy over a decade in insulin-dependent diabetics. Quart J Med. 75:1990;635-646.
10. O'Brien I.A., McFadden J.P., Corrall R.J. The influence of autonomic neuropathy on mortality in insulin-dependent diabetes. Quart J Med. 79:1991;495-502.
11. Rathmann W., Ziegler D., Jahnke M., Haastert B., Gries F.A. Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabetic Med. 20:1993;820-824.
12. Toyry J.P., Siskanen L.K., Mantysaari M.J., Lansimies E.A., Uusitupa M.I.J. Occurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM ten-year follow-up from the diagnosis . Diabetes. 45:1996;308-315.
13. Gerritsen J., Dekker J.M., TenVoorde B.J., Kostense P.J., Heine R.J., Bouter L.M., Heethaar R.M., Stehouwer C.D. Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease the Hoorn Study . Diabetes Care. 24:2001;1793-1798.
14. Fava S., Azzopardi J., Muscat H.A., Fenech F.F. Factors that influence outcome in diabetic subjects with myocardial infarction. Diabetes Care. 16:1993;1615-1618.
15. Stein P.K., Domitrovich P.P., Kleiger R.E., Schechtman K.B., Rottman J.N. Clinical and demographic determinants of heart rate variability in patients post myocardial infarction insights from the Cardiac Arrhythmia Suppression Trial (CAST) . Clin Cardiol. 23:2000;187-194.
16. Risk stratification and survival after myocardial infarction. N Engl J Med. 309:1983;331-336.
17. Bigger J.T., Fleiss J.L., Steinman R.C., Rolnitzky L.M., Kleiger R.E., Rottman J.N. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation. 85:1992;164-171.
18. Kleiger R.E., Miller J.P., Bigger J.T., Moss A.J. Decreased heart rate variability and its association with increased mortality after acute myorcardial infarction. Am J Cardiol. 59:1987;256-262.
19. Bigger J.T., Fleiss J.L., Steinman R.C., Rolnitzky L.M., Kleiger R.E., Rottman J.N. Correlations among time and frequency domain measures of heart period variability two weeks after acute myocardial infarction. Am J Cardiol. 69:1992;891-898.
20. Rottman J.N., Steinman R.C., Albrecht P., Bigger J.T., Rolnitzky L.M., Fleiss J.L. Efficient estimation of the heart period power spectrum suitable for physiologic or pharmacologic studies. Am J Cardiol. 66:1990;1522-1524.
21. Hinkle L.D. Jr, Thaler H.T. Clinical classification of cardiac deaths. Circulation. 65:1982;457-464.
22. Echt D.S., Liebson P.R., Mitchell L.B., Peters R.W., Obias-Manno D., Barker A.H., Arensberg D., Baker A., Friedman L., Greene H.L. Mortality and morbidity in patients receiving encainide, flecainide, or placebo the Cardiac Arrhythmia Suppression Trial . N Engl J Med. 324:1991;781-788.
23. Califf R.M., DeMets D.L. Principles from clinical trials relevant to clinical practice part I . Circulation. 106:2002;1015-1021.
24. Bigger J.T. Relation between left ventricular dysfunction and ventricular arrhythmias after myocardial infarction. Am J Cardiol. 57:(suppl):1986;8B-14B.
25. Bigger J.T., Fleiss J.L., Rolnitzky L.M., Steinman R.C. The ability of several short-term measures of RR variability to predict mortality after myocardial infarction. Circulation. 88:1993;927-934.